المؤلفون: Varon B, Horowitz NA, Khatib H

المصدر: Patient Preference and Adherence, Vol Volume 18, Pp 2159-2167 (2024)

مصطلحات موضوعية: bispecific, bite, glofitamab, epcoritamab, mosunetuzumab, odronextamab, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://www.dovepress.com/novel-bispecific-t-cell-engagers-for-the-treatment-of-relapsed-b-cell--peer-reviewed-fulltext-article-PPA; https://doaj.org/toc/1177-889X

URL الوصول: https://doaj.org/article/492a9fe1fe994174a7ea0df9d01575f3

المؤلفون: Giulio Cassanello, Alejandro Luna de Abia, Lorenzo Falchi

المصدر: OncoImmunology, Vol 13, Iss 1 (2024)

مصطلحات موضوعية: Bispecific antibodies, DLBCL, Epcoritamab, Glofitamab, Immunotherapy, Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2162-402X

URL الوصول: https://doaj.org/article/dd303444c26846a58eba73ffffe1389b

المؤلفون: Alfredo Rivas-Delgado, Ivan Landego, Lorenzo Falchi

المصدر: OncoImmunology, Vol 13, Iss 1 (2024)

مصطلحات موضوعية: Bispecific antibodies, follicular lymphoma, immunotherapy, epcoritamab, glofitamab, mosunetuzumab, Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2162-402X

URL الوصول: https://doaj.org/article/e58a0910b16941e782316f10e9ee17bd

المؤلفون: Osamu Imataki, Shumpei Uchida, Makiko Uemura

المصدر: eJHaem, Vol 5, Iss 6, Pp 1346-1347 (2024)

مصطلحات موضوعية: 18F‐FDG‐PET, epcoritamab, malignant lymphoma, pseudoprogression, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2688-6146

URL الوصول: https://doaj.org/article/437e43a41e7a46f8ad4e83d8271ac276

المؤلفون: Graham McIlroy, Siân Lax, Charlotte Gaskell, Aimee Jackson, Malcolm Rhodes, Tania Seale, Sonia Fox, Lousie Hopkins, Jessica Okosun, Sally F. Barrington, Ingo Ringshausen, Alan G. Ramsay, Maria Calaminici, Kim Linton, Mark Bishton

المصدر: BMC Cancer, Vol 24, Iss 1, Pp 1-13 (2024)

مصطلحات موضوعية: Clinical trial, Relapsed follicular lymphoma, Bayesian power prior methodology, Adaptive design, Epcoritamab, Lenalidomide, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1471-2407

URL الوصول: https://doaj.org/article/569fb28841214450b4923be543937b12

المؤلفون: Lisa Faxén, Marie Edvinsson

المصدر: Upsala Journal of Medical Sciences, Vol 128, Pp 1-7 (2023)

مصطلحات موضوعية: covid-19, anti-cd20, rituximab, epcoritamab, b-cell depletion, b-cell deficiency, persistent infection, immunosuppression, Medicine

وصف الملف: electronic resource

Relation: https://ujms.net/index.php/ujms/article/view/9807/16287; https://doaj.org/toc/0300-9734; https://doaj.org/toc/2000-1967

URL الوصول: https://doaj.org/article/a24d2f5b0a9944c78b775bf6bd22a6fe

المؤلفون: Elena Bayly-McCredie, Maxine Treisman, Salvatore Fiorenza

المصدر: International Journal of Molecular Sciences, Vol 25, Iss 17, p 9736 (2024)

مصطلحات موضوعية: large B-cell lymphoma, diffuse large B-cell lymphoma, bispecific antibody, epcoritamab, glofitamab, mosunetuzumab, Biology (General), QH301-705.5, Chemistry, QD1-999

Relation: https://www.mdpi.com/1422-0067/25/17/9736; https://doaj.org/toc/1661-6596; https://doaj.org/toc/1422-0067; https://doaj.org/article/fb6d30c792c24194a1ff3edd78894e1e

الاتاحة: https://doi.org/10.3390/ijms25179736
https://doaj.org/article/fb6d30c792c24194a1ff3edd78894e1e

المؤلفون: McIlroy, G, Lax, S, Gaskell, C, Jackson, A, Rhodes, M, Seale, T, Fox, S, Hopkins, L, Okosun, J, Barrington, SF, Ringshausen, I, Ramsay, AG, Calaminici, M, Linton, K, Bishton, M

المصدر: BMC Cancer , 24 (1) , Article 370. (2024)

مصطلحات موضوعية: Adaptive design, Bayesian power prior methodology, Clinical trial, Epcoritamab, Lenalidomide, Relapsed follicular lymphoma, Humans, Lymphoma, Follicular, Positron Emission Tomography Computed Tomography, Arm, Bayes Theorem, Quality of Life, Treatment Outcome, Randomized Controlled Trials as Topic, Multicenter Studies as Topic, Clinical Trials, Phase II as Topic

وصف الملف: text

Relation: https://discovery.ucl.ac.uk/id/eprint/10190303/1/s12885-024-12112-0.pdf; https://discovery.ucl.ac.uk/id/eprint/10190303/

الاتاحة: https://discovery.ucl.ac.uk/id/eprint/10190303/1/s12885-024-12112-0.pdf
https://discovery.ucl.ac.uk/id/eprint/10190303/

المؤلفون: Khalil Saleh, Rita Khoury, Nadine Khalife, Claude Chahine, Rebecca Ibrahim, Zamzam Tikriti, Axel Le Cesne

المصدر: Journal of Personalized Medicine, Vol 14, Iss 7, p 666 (2024)

مصطلحات موضوعية: diffuse large B-cell lymphoma, epcoritamab, glofitamab, mosunetusumab, odronextamab, bispecific antibodies, Medicine

Relation: https://www.mdpi.com/2075-4426/14/7/666; https://doaj.org/toc/2075-4426; https://doaj.org/article/0bb36865056b4004a65b6c04862c605c

الاتاحة: https://doi.org/10.3390/jpm14070666
https://doaj.org/article/0bb36865056b4004a65b6c04862c605c

المؤلفون: Molica, Stefano, Rossi, Marco, Allsup, David

مصطلحات موضوعية: Epcoritamab, Diffuse large B-cell lymphoma, Follicular lymphoma, Chronic lymphocytic leukemia

Relation: https://hull-repository.worktribe.com/output/4546257; Expert Opinion on Biological Therapy; Volume 24; Issue 1-2; Pagination 1-5; https://hull-repository.worktribe.com/file/4546257/1/Accepted%20manuscript

الاتاحة: https://hull-repository.worktribe.com/file/4546257/1/Accepted%20manuscript
https://hull-repository.worktribe.com/output/4546257
https://doi.org/10.1080/14712598.2024.2310148

المؤلفون: Jana Mihályová, Katarína Hradská, Tomáš Jelínek, Benjamin Motais, Piotr Celichowski, Roman Hájek

المصدر: International Journal of Molecular Sciences; Volume 22; Issue 21; Pages: 11470

مصطلحات موضوعية: immunotherapy, bispecific antibodies, antibody-drug conjugates, brentuximab vedotin, polatuzumab vedotin, mosenutuzumab, epcoritamab, glofitamab

جغرافية الموضوع: agris

وصف الملف: application/pdf

Relation: Molecular Pathology, Diagnostics, and Therapeutics; https://dx.doi.org/10.3390/ijms222111470

الاتاحة: https://doi.org/10.3390/ijms222111470

المؤلفون: Benjamin Motais, Tomas Jelinek, Roman Hájek, Piotr Celichowski, Jana Mihalyova, Katarina Hradska

المصدر: International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 11470, p 11470 (2021)

مصطلحات موضوعية: Immunoconjugates, Lymphoma, B-Cell, QH301-705.5, medicine.medical_treatment, Chronic lymphocytic leukemia, antibody-drug conjugates, Review, polatuzumab vedotin, Catalysis, Targeted therapy, Inorganic Chemistry, Chemoimmunotherapy, immune system diseases, brentuximab vedotin, hemic and lymphatic diseases, medicine, Animals, Humans, Biology (General), Physical and Theoretical Chemistry, QD1-999, Molecular Biology, Spectroscopy, CD20, biology, business.industry, epcoritamab, Organic Chemistry, Antibodies, Monoclonal, General Medicine, Immunotherapy, medicine.disease, Lymphoproliferative Disorders, Chimeric antigen receptor, Computer Science Applications, Polatuzumab vedotin, mosenutuzumab, Chemistry, Cancer research, biology.protein, Blinatumomab, immunotherapy, bispecific antibodies, business, medicine.drug, glofitamab

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61098cd287c27cb9e2f0e1928c3fede1
http://europepmc.org/articles/PMC8584080

المؤلفون: Danecki, Michał, Jurczak, Wojciech

المصدر: Acta Haematologica Polonica; Online first

مصطلحات موضوعية: bispecific antibodies, diffuse large B-cell lymphoma, epcoritamab, glofitamab, refractory, relapsed

وصف الملف: application/pdf

Relation: https://journals.viamedica.pl/acta_haematologica_polonica/article/view/100752

الاتاحة: https://journals.viamedica.pl/acta_haematologica_polonica/article/view/100752

المؤلفون: Faxén, Lisa, Edvinsson, Marie

مصطلحات الفهرس: COVID-19, anti-CD20, rituximab, epcoritamab, B-cell depletion, B-cell deficiency, persistent infection, immunosuppression, Infectious Medicine, Infektionsmedicin, Article in journal, info:eu-repo/semantics/article, text

URL: http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-519137
Upsala Journal of Medical Sciences, 0300-9734, 2023, 128